Loading...
Applying Precision to the Management of BRAF-Mutant Metastatic Colorectal Cancer
Identifying the presence or absence of a BRAF(V600E) mutation is paramount for the management of patients with metastatic colorectal cancer (mCRC) as there is distinct predictive and prognostic implications, as well as unique therapeutic approaches for this molecular subtype. Traditional cytotoxic d...
Na minha lista:
| Udgivet i: | Target Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7583680/ https://ncbi.nlm.nih.gov/pubmed/32889679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-020-00747-5 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|